Akebia Therapeutics
AKBA
#6961
Rank
HK$3.17 B
Marketcap
HK$15.08
Share price
4.02%
Change (1 day)
117.03%
Change (1 year)

Earnings for Akebia Therapeutics (AKBA)

Earnings in 2024 (TTM): -HK$0.32 Billion

According to Akebia Therapeutics's latest financial reports the company's current earnings are HK$0.17 Billion. In 2023 the company made an earning of -HK$0.41 Billion, an increase over its 2022 earnings that were of -HK$0.74 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Akebia Therapeutics from 2013 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -HK$0.32 Billion-21.61%
2023 -HK$0.41 Billion-45.12%
2022 -HK$0.74 Billion-66.55%
2021 -HK$2.2 Billion-26.24%
2020 -HK$2.99 Billion33.94%
2019 -HK$2.23 Billion66.52%
2018 -HK$1.34 Billion123.53%
2017 -HK$0.6 Billion-43.34%
2016 -HK$1.06 Billion123.58%
2015 -HK$0.48 Billion63.95%
2014 -HK$0.29 Billion181.24%
2013 -HK$0.11 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
HK$36.38 B-11,669.66%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$98.99 B-31,582.12%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
HK$143.02 B-45,584.89%๐Ÿ‡บ๐Ÿ‡ธ USA
-HK$1.38 Billion 338.06%๐Ÿ‡บ๐Ÿ‡ธ USA